Chemical Formula: C21H16N4O2

Chemical Formula C21H16N4O2

Found 13 metabolite its formula value is C21H16N4O2

1-Methyl-1,4-[(1H-indole-2,3-diyl)methylene]-1,4-dihydro-2H-pyrazino[2,1-b]quinazoline-3,6-dione

1-Methyl-1,4-[(1H-indole-2,3-diyl)methylene]-1,4-dihydro-2H-pyrazino[2,1-b]quinazoline-3,6-dione

C21H16N4O2 (356.12731959999996)


   

METHYL 4-(4-(3-(PYRIDIN-2-YL)-1H-PYRAZOL-4-YL)PYRIDIN-2-YL)BENZOATE

METHYL 4-(4-(3-(PYRIDIN-2-YL)-1H-PYRAZOL-4-YL)PYRIDIN-2-YL)BENZOATE

C21H16N4O2 (356.12731959999996)


   

4-[3-(1H-Benzimidazol-2-YL)-1H-indazol-6-YL]-2-methoxyphenol

4-[3-(1H-Benzimidazol-2-YL)-1H-indazol-6-YL]-2-methoxyphenol

C21H16N4O2 (356.12731959999996)


   

2-(3-nitrophenyl)-N-(phenylmethyl)-4-quinazolinamine

2-(3-nitrophenyl)-N-(phenylmethyl)-4-quinazolinamine

C21H16N4O2 (356.12731959999996)


   

6-(1,3-benzodioxol-5-yl)-N-(3-pyridinylmethyl)-4-quinazolinamine

6-(1,3-benzodioxol-5-yl)-N-(3-pyridinylmethyl)-4-quinazolinamine

C21H16N4O2 (356.12731959999996)


   

(2Z)-2-[(2-methoxyanilino)methylidene]-3-methyl-1-oxopyrido[1,2-a]benzimidazole-4-carbonitrile

(2Z)-2-[(2-methoxyanilino)methylidene]-3-methyl-1-oxopyrido[1,2-a]benzimidazole-4-carbonitrile

C21H16N4O2 (356.12731959999996)


   

N-[(E)-(1,3-diphenyl-1H-pyrazol-4-yl)methylidene]furan-2-carbohydrazide

N-[(E)-(1,3-diphenyl-1H-pyrazol-4-yl)methylidene]furan-2-carbohydrazide

C21H16N4O2 (356.12731959999996)


   

N-(1,3-benzodioxol-5-ylmethyl)-6-(3-pyridinyl)-4-quinazolinamine

N-(1,3-benzodioxol-5-ylmethyl)-6-(3-pyridinyl)-4-quinazolinamine

C21H16N4O2 (356.12731959999996)


   

(Rac)-PF-06256142

(Rac)-PF-06256142

C21H16N4O2 (356.12731959999996)


(Rac)-PF-06256142 is the less effective enantiomer of PF-06256142 (HY-119943). (Rac)-PF-06256142 is an agonist of D1 receptor, with an EC50 of 107 nM. (Rac)-PF-06256142 can be used for the research of schizophrenia and Parkinson's disease[1].

   

PF-06256142

PF-06256142

C21H16N4O2 (356.12731959999996)


PF-06256142 is a potent, selective, CNS-penetrant and orally active agonist of the D1 receptor, with an EC50 and Ki of 33 nM and 12 nM, respectively. PF-06256142 has the potential for the research of schizophrenia and Parkinson's disease[1].

   

(1r,12r)-24-hydroxy-1-methyl-3,13,21,23-tetraazahexacyclo[10.10.2.0²,¹⁰.0⁴,⁹.0¹³,²².0¹⁵,²⁰]tetracosa-2(10),4,6,8,15,17,19,21,23-nonaen-14-one

(1r,12r)-24-hydroxy-1-methyl-3,13,21,23-tetraazahexacyclo[10.10.2.0²,¹⁰.0⁴,⁹.0¹³,²².0¹⁵,²⁰]tetracosa-2(10),4,6,8,15,17,19,21,23-nonaen-14-one

C21H16N4O2 (356.12731959999996)


   

15'-hydroxy-12'-methyl-2',10',16'-triazaspiro[indole-3,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaen-3'-one

15'-hydroxy-12'-methyl-2',10',16'-triazaspiro[indole-3,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaen-3'-one

C21H16N4O2 (356.12731959999996)


   

(1'r,3r,12'r)-15'-hydroxy-12'-methyl-2',10',16'-triazaspiro[indole-3,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaen-3'-one

(1'r,3r,12'r)-15'-hydroxy-12'-methyl-2',10',16'-triazaspiro[indole-3,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaen-3'-one

C21H16N4O2 (356.12731959999996)